Sue Siegel is CEO of GE Ventures, GE’s growth and innovation business comprised of new market development, equity investing, new business creation and licensing. Sue has more than 30 years of experience in corporate and venture capital. Previously, as a financial VC, Sue led investments in personalized medicine, digital health, and life sciences at Silicon Valley-based Mohr Davidow Ventures.
Before venture capital, she was President and Board Member of Affymetrix (NASDAQ: AFFX), where she drove the company’s transformation from a pre-revenue start up to a global, multi-billion dollar market cap genomics leader. Prior to that, Sue drove strategy, technology development, licensing, manufacturing, as well as new market creation at Bio-Rad, DuPont, and Amersham. Sue has served on many private and public corporate boards. She currently serves on the Boards of: Stanford Hospital Board’s IT Committee, Harvard Partners’ Innovation Advisory Board, the Cleveland Clinic’s Innovation Council, University of California’s Innovation Council, and serves on the Executive Committee of Santa Clara University’s Center for Science, Technology, and Society’s Advisory Board.
She is a member of YPO-WPO, Women Corporate Directors, and a Henry Crown Fellow of the Aspen Institute. In the bestselling business book: Multipliers: How The Best Leaders Make Everyone Smarter, Sue was a featured “Multiplier.” She was recognized as one of “The 100 Most Influential Women in Silicon Valley” and Fortune’s “34 Leaders Who Are Changing Health Care.”